Table: Taiko Pharmaceutical -2016/17 group results

Taiko Pharmaceutical

12/05/2017 07:00

May 12 (Reuters)-  
          Taiko Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales             8.29            8.33           8.70                   
                 (-0.4 pct)      (-7.3 pct)     (+4.9 pct)                
  Operating         1.55            1.35           1.55                   
                 (+14.7 pct)     (-47.3 pct)    (+0.4 pct)                
  Recurring         1.41            1.31           1.30                   
                 (+7.7 pct)      (-52.9 pct)    (-7.6 pct)                
  Net 
  Net               1.05           840 mln        900 mln                 
                 (+24.9 pct)     (-52.6 pct)    (-14.2 pct)               
  EPS             76.45 yen       65.23 yen      63.74 yen                
  EPS Diluted     75.81 yen       63.83 yen                               
  Ann Div         20.00 yen       15.00 yen      15.00 yen                
  -Q2 Div            NIL             NIL            NIL                   
  -Q4 Div         20.00 yen       15.00 yen      15.00 yen                
   
  NOTE - Taiko Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T 
  ((Tokyo Headline News Desk +813 6441 1812))